Differential pulse pressure response to various antihypertensive drug families

被引:6
作者
Karpanou, E. A.
Vyssoulis, G. P.
Stefanadis, C. I.
Cokkinos, D. V.
机构
[1] Onassis Cardiac Surg Ctr, Dept Cardiol 1, Athens, Greece
[2] Univ Athens, Hippokrat Hosp, Cardiol Dept 1, Athens, Greece
关键词
pulse pressure; left ventricular hypertrophy; antihypertensive drugs;
D O I
10.1038/sj.jhh.1002069
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Pulse pressure ( PP) is emerging as a major pressure predictor of cardiac disease. The study comprised 10 185 untreated patients with essential hypertension. A total of 5395 men and 4790 women 56 +/- 13 years old, with uncomplicated essential hypertension, after a 15-day washout period and after 6 months of antihypertensive monotherapy were included. All patients included in the final cohort were responders and had normalized their blood pressure. PP was decreased least with diuretics ( - 5 mm Hg) and most with angiotensin II receptor blockers (ARBs) and calcium antagonists ( = 15 mm Hg), followed by angiotensin-converting enzyme inhibitors (ACEI) ( - 12mm Hg) alpha- and beta-blockers ( - 10 and -9 mm Hg), differentiating among antihypertensive classes ( P<0.001). The magnitude of PP fall was related to the degree of left ventricular (LV) mass reduction (P<0.001), seen best with ARBs ( r = 0.42) and least with ACEIs ( r = 0.18). Of the antihypertensive medications used in everyday practice, PP decrease may be achieved best with ARBs and calcium antagonists, whereas diuretics confer poor response. PP was decreased least with diuretics ( - 5 mm Hg) and most with ARBs and calcium channel blockers ( - 15 mm Hg), followed by ACEI ( - 12 mm Hg) alpha- and beta-blockers ( - 10 and - 9 mm Hg), differentiating among antihypertensive classes ( P<0.001). Of the antihypertensive medications used in everyday practice, PP decrease may be achieved best with ARBs and calcium antagonists.
引用
收藏
页码:765 / 771
页数:7
相关论文
共 31 条
[1]   Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects [J].
Benetos, A ;
Rudnichi, A ;
Safar, M ;
Guize, L .
HYPERTENSION, 1998, 32 (03) :560-564
[2]   Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients [J].
Blacher, J ;
Staessen, JA ;
Girerd, X ;
Gasowski, J ;
Thijs, L ;
Liu, LS ;
Wang, JG ;
Fagard, RH ;
Safar, ME .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (08) :1085-1089
[3]   Increased pulse pressure and risk of heart failure in the elderly [J].
Chae, CU ;
Pfeffer, MA ;
Glynn, RJ ;
Mitchell, GF ;
Taylor, JO ;
Hennekens, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (07) :634-639
[4]   Antihypertensive medication class and pulse pressure in the elderly: Analysis based on the third national health and nutrition examination survey [J].
Chang, JJ ;
Luchsinger, JA ;
Shea, S .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (07) :536-542
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[7]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[8]   Aortic pulse pressure is related to the presence and extent of coronary artery disease in men undergoing diagnostic coronary angiography: A multicenter study [J].
Danchin, N ;
Benetos, A ;
Lopez-Sublet, M ;
Demicheli, T ;
Safar, M ;
Mourad, LJ .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (02) :129-133
[9]   Is high pulse pressure a marker of preclinical cardiovascular disease? [J].
de Simone, G ;
Roman, MJ ;
Alderman, MH ;
Galderisi, M ;
de Divitiis, O ;
Devereux, RB .
HYPERTENSION, 2005, 45 (04) :575-579
[10]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618